Sandra Coppens

Sandra Coppens is a dedicated virology researcher at the Prince Leopold Institute of Tropical Medicine (ITG) in Antwerp, Belgium, where she has maintained an active research profile since at least 1996. Her work focuses on emerging viral pathogens with significant public health implications, particularly arboviruses and other emerging infectious disease threats.

Dr. Coppens' research interests center on viral pathogenesis, molecular virology, and diagnostic development, with particular expertise in Chikungunya virus (her primary research focus at 100%), Monkeypox virus (39%), SARS-related viruses (34%), and flaviviruses. Her fingerprint analysis reveals substantial contributions to understanding viral genomic plasticity, host-pathogen interactions, and viral adaptation mechanisms. She has developed particular expertise in working with A549 cells for viral adaptation studies and has contributed significantly to routine diagnostic test development and validation.

Analysis of her publication trends shows a clear shift toward emerging viral threats, with substantial contributions during the mpox outbreak (2022-2023) and the COVID-19 pandemic (2020-2022). Her recent work demonstrates expertise in viral surveillance, diagnostic assay development, and understanding viral evolution in response to host constraints. The high citation counts on her monkeypox research (212 citations for the Nature Medicine paper) indicate significant impact in the field.

Dr. Coppens collaborates extensively with researchers across Belgium and internationally, particularly with colleagues at ITG including Van Esbroeck, M., Ariën, K.K., and Heyndrickx, L. Her research appears in high-impact journals including Nature Medicine, Viruses, and Archives of Virology, demonstrating the quality and relevance of her work to the broader scientific community.